Sort
48,018 grants matching “immunotherapy”
Manipulating DNA Damage-response Signaling for the Treatment of Type 1 Diabetes
$446,790Jonathan David Katz · Cincinnati Childrens Hosp Med Ctr · R01 · FY2019 · DK
Manipulating DNA Damage-response Signaling for the Treatment of Type 1 Diabetes
$446,790Jonathan David Katz · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · DK
Manipulating DNA Damage-response Signaling for the Treatment of Type 1 Diabetes
$446,790Jonathan David Katz · Cincinnati Childrens Hosp Med Ctr · R01 · FY2020 · DK
Manipulating DNA Damage-response Signaling for the Treatment of Type 1 Diabetes
$446,790Jonathan David Katz · Cincinnati Childrens Hosp Med Ctr · R01 · FY2021 · DK
Immunobiology of Myeloid and Lymphoid Cells
$446,788William R Green · Dartmouth College · T32 · FY2007 · AI
SynerGel: A Novel Tumor Microenvironment-Modulating Hydrogel for Local Immunotherapy
$446,690Simon Young · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · DE
Two Compartment Models to Improve Brain Tumor Therapy
$446,685Oregon Health And Science University · R01 · FY2003 · NS
Epigenetic Synergy Between DNMT and EZH1/2 Inhibitors for Therapy in Solid Tumors
$446,575Scott Rothbart · Coriell Institute For Medical Research · P50 · FY2023 · CA
Epigenetic Synergy Between DNMT and EZH1/2 Inhibitors for Therapy in Solid Tumors
$446,575Scott Rothbart · Coriell Institute For Medical Research · P50 · FY2022 · CA
WEE1 inhibition and tumor immunity
$446,500Bin Zhang · Northwestern University At Chicago · R01 · FY2018 · CA
Core B: Biostatistics and Bioinformatics
$446,494Ted Gooley · Fred Hutchinson Cancer Research Center · P01 · FY2021 · CA
ADPKD: Understanding immunosuppression mechanisms and discovering treatment
$446,491Xiaogang Li · Mayo Clinic Rochester · R01 · FY2024 · DK
Targeting epigenetic machinery to overcome myeloid cell-mediated resistance to anti-PD-1 therapy in GBM
$446,457Sangeeta Goswami · University Of Tx Md Anderson Can Ctr · R37 · FY2024 · CA
Combining AD Epitope Vaccine with Innate Immunity
$446,424David Hastings Cribbs · University Of California-Irvine · R01 · FY2011 · NS
Transport of Effector T cells and Nano-DC vaccine in Breast Cancer
$446,417Rongfu Wang · Methodist Hospital Research Institute · U54 · FY2020 · CA
MECHANISMS OF MURINE TUMOR ERADICATION BY IMMUNOTHERAPY
$446,356University Of Washington · R37 · FY2001 · CA
Targeting Lipid Metabolism in the Tumor Microenvironment
$446,352Ashani T Weeraratna · Wistar Institute · P01 · FY2020 · CA
Rational in situ programming of cancer vaccine-responding T-cell clones
$446,342Matthias Stephan · Fred Hutchinson Cancer Center · R01 · FY2023 · CA
An image-guided immunotherapy and hyperthermia delivery device to overcome barriers to tumor immunity for advanced hepatocellular carcinoma
$446,342Rahul Anil Sheth · University Of Tx Md Anderson Can Ctr · R37 · FY2024 · CA
Understanding the Role of Mucosal Antigen Presenting Cells in Regulating Immune R
$446,250Bali Pulendran · Emory University · R37 · FY2015 · AI
Understanding the Role of Mucosal Antigen Presenting Cells in Regulating Immune R
$446,250Bali Pulendran · Emory University · R37 · FY2016 · AI
Understanding the Role of Mucosal Antigen Presenting Cells in Regulating Immune R
$446,250Bali Pulendran · Emory University · R37 · FY2014 · AI
Targeting innate immune pathways in breast cancers with chromosomal instability
$446,239Samuel F Bakhoum · Sloan-Kettering Inst Can Research · P50 · FY2022 · CA
Preventing follicular lymphoma progression and transformation through precision therapy
$446,170Wendy Beguelin · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · CA
Targeting HSP70 for MelanomaTherapy
$446,169Maureen E Murphy · Wistar Institute · P01 · FY2023 · CA